Our study reveals a novel mechanistic insight for breast cancer metastasis mediated by the FOXO3a-miRNA-VEGF/NRP1 signaling axis and highlights the potential of targeting FOXO3a-miR-29b/miR-338 as a novel therapeutic strategy for breast cancer (Fig. 7F). Here, FOXO3 is linked to breast carcinoma.